Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

Share Price Information for Iconic Labs (ICON)

Share Price is delayed by 15 minutes
Get Live Data
2.20    0.55 (33.33%)
Bid:
2.00
Ask:
2.40
Spread: 0.40 (20.00%)
Market Cap: £352.88k
ICON Live PriceLast checked at - London Stock Exchange

Intraday Iconic Labs Share Chart

Board Changes

Today 07:00

RNS Number : 5638K
Iconic Labs PLC
01 July 2026
 

Iconic Labs PLC

 

("Iconic" or the "Company")

 

Board Changes

Iconic Labs PLC (LSE: ICON) announces that after more than two years of serving as a Director of the Company, Victor Humberdot is stepping down from this position with immediate effect.

The Company would like to thank Mr Humberdot for his support during this period.

The Company also announces the appointment of Bertalan Jászkuti (aged 52) as Director with immediate effect. Bertalan is a health economist and currently serves as Head of Innovation Funding at Syreon Research Institute Ltd. Prior to his current position, he held senior roles focusing on corporate finance advisory, mergers & acquisitions, fundraising and equity capital market transactions including at Deloitte Advisory and Management Consulting where he was for six years, in addition to his own life-sciences focused boutique investment firm. Over the past 25 years Bertalan has served a wide variety of clients including entrepreneurs seeking sales or fundraising as well as institutional private equity funds, private investors and large multinational companies seeking capital deployment. Bertalan completed all exams at the Chartered Association of Certified Accountants (ACCA) and he holds the ICAEW's Corporate Finance (CF) qualification.

 

For any further information or enquiries please contact:

 

Iconic Labs

John Farquharson, Chief Executive Officer

via Yellow Jersey PR

AlbR Capital Limited

David Coffman / Daniel Harris

Tel: +44 (0) 20 7469 0930

 

Yellow Jersey PR

Charles Goodwin

Annabelle Wills

 

Tel: +44 (0) 20 3004 9512

 

iconic@yellowjerseypr.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPUCAMUPQUAG
Date   Source Headline
13th Sep 201912:20 pmRNSHolding(s) in Company
12th Sep 201911:45 amRNSManagement Services Agreement
9th Sep 20197:00 amRNSAcquisition
30th Aug 20194:40 pmRNSSecond Price Monitoring Extn
30th Aug 20194:35 pmRNSPrice Monitoring Extension
23rd Aug 20194:40 pmRNSSecond Price Monitoring Extn
23rd Aug 20194:35 pmRNSPrice Monitoring Extension
23rd Aug 20192:30 pmRNSQ&A Document
16th Aug 20192:51 pmRNSQ&A Document
16th Aug 20192:50 pmRNSHolding(s) in Company
16th Aug 20192:50 pmRNSIssue of Equity
16th Aug 20192:50 pmRNSHolding(s) in Company
6th Aug 20194:40 pmRNSSecond Price Monitoring Extn
6th Aug 20194:35 pmRNSPrice Monitoring Extension
6th Aug 20197:00 amRNSAcquisition and Financing
16th Jul 201911:10 amRNSHolding(s) in Company
15th Jul 20194:24 pmRNSChange of Name to Iconic Labs Plc
15th Jul 201912:15 pmRNSHolding(s) in Company
10th Jul 20193:59 pmRNSName Change to Iconic Labs Plc and Results of GM
26th Jun 20194:45 pmRNSHolding(s) in Company
26th Jun 20194:37 pmRNSHolding(s) in Company
24th Jun 20193:10 pmRNSNotice of General Meeting
17th Jun 201910:38 amRNSCorrection: Conversion of Securities
17th Jun 20197:25 amRNSEnd of Existing Financing Agreement and Lock-In
17th Jun 20197:24 amRNSConversion of Securities
17th Jun 20197:00 amRNSHolding(s) in Company
6th Jun 20192:00 pmRNSHolding(s) in Company
3rd Jun 20197:00 amRNSNew Engagement for Iconic Labs
29th May 201911:40 amRNSHolding(s) in Company
29th May 201911:35 amRNSConversion Notices
29th May 201911:30 amRNSHolding(s) in Company
24th May 201912:00 pmRNSHolding(s) in Company
21st May 20191:21 pmRNSHolding(s) in Company
21st May 20191:20 pmRNSConversion Notice
20th May 20192:45 pmRNSAppointment of Company Secretary
13th May 20197:00 amRNSOperational Update
10th May 201912:15 pmRNSHolding(s) in Company
9th May 201910:42 amRNSHolding(s) in Company
9th May 201910:40 amRNSHolding(s) in Company
3rd May 20193:15 pmRNSTurner Pope Investor Evening 13 May
3rd May 20192:15 pmRNSHolding(s) in Company
1st May 20194:41 pmRNSSecond Price Monitoring Extn
1st May 20194:35 pmRNSPrice Monitoring Extension
1st May 20194:05 pmRNSCorporate Update
1st May 20194:00 pmRNSFinancing Agreement
29th Apr 20192:15 pmRNSHolding(s) in Company
29th Apr 201911:07 amRNSSecond Price Monitoring Extn
29th Apr 201911:00 amRNSPrice Monitoring Extension
29th Apr 201910:38 amRNSTR-1: NOTIFICATION OF MAJOR HOLDINGS 
29th Apr 201910:29 amRNSConversion of Loan Notes & Issue of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.